Sort
23,748 grants matching “melanoma”
Cancer Deep Phenotype Extraction from Electronic Medical Records
$993,015Guergana K. Savova · Boston Children'S Hospital · U24 · FY2018 · CA
Immunomodulatory biomaterial to enhancing T-cell responses to triple negative breast cancer
$992,724Dashtimoghadam Erfan · Symphony Biosciences, Inc. · R44 · FY2024 · CA
Studies of Receptor Interactions and Effects of Alarmins
$991,767Joost J Oppenheim · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Characterization of Cancer Stem Cells
$991,766William Farrar · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Determining the Fate of Transmembrane Proteins
$991,635Allan M Weissman · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
A single-cell device to capture and analyze rare T-cells from solid tumors.
$991,227Timothy S McConnell · Isoplexis, Inc. · R44 · FY2017 · CA
Bifunctional T cell receptor based immunotherapeutics
$990,016Hing C. Wong · Altor Bioscience. Llc · R44 · FY2010 · CA
Dissecting the enhancer logic governing immune cell fate decisions
$990,000Debattama Rai Sen · Massachusetts General Hospital · DP2 · FY2025 · AI
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
$988,986Suresh Ambudkar · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
EPIGENETIC REGULATION OF THE IMMUNE SYNAPSE IN MELANOMA
$988,016Mayo Clinic Jacksonville (A Nonprofit Corporation) · · FY2022 · Defense Health Agency
Immunomodulatory biomaterial to enhancing T-cell responses to triple negative breast cancer
$987,911Dashtimoghadam Erfan · Symphony Biosciences, Inc. · R44 · FY2025 · CA
RARE MELANOMA TRANSLATIONAL CORE: COLLABORATIVE HUB TO ADVANCE THE TREATMENT OF RARE ACRAL AND MUCOSAL MELANOMAS
$986,518The Johns Hopkins University · · FY2025 · Defense Health Agency
Preclinical GEM and GDA Models of Primary and Metastatic Melanoma
$986,350Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Improving the Efficacy of Dendritic Cell Vaccines
$985,145Jacques F Banchereau · Baylor Research Institute · P01 · FY2008 · CA
Programming T Cell Fates for Therapeutic Use
$984,972Luca Gattinoni · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
IntellipulseTM Platform Technology for Effective Delivery of Therapeutic Agents
$984,830Gary Strange · Ef Therapeutics Corp. · R44 · FY2025 · CA
Immunohistochemical analysis of tumors
$984,553Markku Miettinen · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Development of 7HP349, an oral integrin activator to enhance therapeutic responses to immune checkpoint inhibitors
$984,409Upendra Marathi · 7 Hills Pharma, Llc · R44 · FY2020 · CA
Determining the Fate of Transmembrane Proteins
$983,942Allan M Weissman · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Viral And Cellular Factors Governing Efficient Gene Delivery
$983,499Maribeth V. Eiden · National Institute Of Mental Health · ZIA · FY2009 · MH
Identification of Novel Oncogenic Signaling Pathways using Viral Perturbations
$983,479James A Decaprio · Dana-Farber Cancer Inst · R35 · FY2024 · CA
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
$983,087Mary N. Carrington · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Genetic Epidemiology of Lung Cancer
$982,565Marshall W Anderson · University Of Cincinnati · U01 · FY2009 · CA
Advancing a Glioma Immunotherapy
$981,388Dwaine Franklin Emerich · In Cytu, Inc. · R44 · FY2013 · NS
Missouri Valley Cancer Consortium CCOP
$980,000Missouri Valley Cancer Consortium, Inc. · U10 · FY2002 · CA